Evidence map›Paper›PMID 23043253›Full record

ArticleBritish journal of haematology2012

Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients.

Egil S Blix, Jonathan M Irish, Anne Husebekk, Jan Delabie, Anne M Tierens, June H Myklebust, Arne Kolstad

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Human Germinal Center B Cells Differ from Naïve and Memory B Cells in CD40 Expression and CD40L-Induced Signaling Response.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2019
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Egil S Blix
Jonathan M Irish
Anne Husebekk
Jan Delabie
Anne M Tierens
June H Myklebust
Arne Kolstad
Oslo University Hospital · NOUiT The Arctic University of Norway · NOBaxter (United States) · US

Funding

Targeting the B Cell Receptor Signaling Network in LymphomaR00CA143231 · NCI · VANDERBILT UNIVERSITY · PI IRISH, JONATHAN MICHAEL · 2012 to 2014
$715k
Targeting the B Cell Receptor Signaling Network in LymphomaK99CA143231 · NCI · STANFORD UNIVERSITY · PI IRISH, JONATHAN MICHAEL · 2009 to 2009
$136k
NCI NIH HHS K99 CA143231NCI NIH HHS R00 CA143231
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedCD40 AntigensFemaleHumansLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-Cell, Marginal ZoneMaleMiddle AgedPrognosisProto-Oncogene Proteins c-bcrSignal TransductionBCR protein, humanCD40 AntigensProto-Oncogene Proteins c-bcr

Identifiers

PMID23043253
PMCPMC3767388
OpenAlexW2051208771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.